Articles listed by section
Results for Feature
Feature | April 21, 2020
Working together to accelerate medical innovation
Chinese and Japanese participants gathered in Chengdu to discuss advanced medicine
Feature | December 20, 2019
Medical technology advancing along key fronts
Disruptive strategies for treating diseases, new medical devices and big data are set to transform medical treatment
Feature | August 8, 2019
Spinal cord treatment using stem cells
After a small-scale clinical trial, a promising stem-cell treatment for spinal cord injuries is now available in Japan
Feature | December 21, 2018
Producing fit and active centenarians
TRI is striving to enliven society by harnessing the power of regenerative medicine
Feature | August 23, 2018
Collaborating against cancer
Convening for the fourth year, Japanese and Taiwanese academics continue to push forward together to tackle critical medical science issues.
Feature | June 13, 2018
Casting a wider net for big data benefits
Embracing big data promises to expand the knowledge brought by clinical trials and lead to safer therapies
Feature | April 19, 2018
Launching a wealth of medical knowledge
An authoritative source of medical information for almost 120 years, the MSD manuals are now freely available online in Japanese
Feature | March 7, 2018
Living well to a hundred and beyond
The public were given a preview of therapies that promise to preserve the quality of life of people well into old age
Feature | March 7, 2018
The harmony of standardized data
Translational and clinical research is hampered by the ‘dissonant notes’ of poor efficacy systems and a lack of data standards, claim researchers and policymakers. Fixing these problems can save lives.
Feature | October 26, 2017
Stem cell therapies demonstrating their potential
CD34 positive stem cells could be used to treat a wide range of medical conditions
Feature | July 4, 2017
Clinical trials on trial
Poor standards in clinical trials waste time and money, and cost lives. Global cooperation is the only way to raise the bar.
Feature | July 4, 2017
From lab to clinic
TRI director Masanori Fukushima says considering disease mechanisms are the key to providing medicines to ease the journey into old age